of biopharmaceuticals, making innovation accessible and economically viable so that transformative treatments reach those in need. With a strong technical team and state-of-the-art infrastructure under expansion, Biotimize addresses a critical gap in LATAM: the region’s heavy dependence on imported biopharmaceuticals. By enabling local and international companies to develop and manufacture products closer to patients, Biotimize strengthens health sovereignty, reduces costs, and accelerates access to life-saving therapies.